Conférences - Médecine translationnelle, essais cliniques

Sélecionner un pays:
Allemagne (1) - Autriche (1) - Espagne (1) - France (1) - Italie (2) - Royaume-Uni (5)

TOUS LES PAYS

1
AIS 2019 — 7th Antibody Industrial Symposium
24 jui 2019 - 25 jui 2019 • Tours, France
Résumé:
The 7th Antibody Industrial Symposium (AIS2019) will be held on June 24-25, 2019 in Tours, France. This year edition will focus on Harnessing the Immune System with mAbs, a major topic chosen by the AIS Scientific Advisory Board constituted by Pierre Fabre, Servier, IRCM, MabDesign, Sanofi, OSE Immunotherapeutics, LFB, CEPR, IGMM, LabEx MabImprove, and Tours University. Join more than 300 experts expected for this new edition, working in the field of mAbs and related services and technologies.
Contact:
Email.: ana-sofia.antunes@mabdesign.fr
Sujets:
The topics addressed during this congress are: - Harnessing the Immune system with Immunomodulatory therapeutic Antibodies; - Immunomodulation via cell membrane antigens; - Immunomodulation with therapeutic antibodies – new strategies & technologies; - Immunomodulation via Soluble Antigens; - Immunomodulation FC – FcyR interactions.
Identifiant de l'évènement:
1197896
Sujets apparentés:
2
MS Frontiers 2019
04 jul 2019 - 05 jul 2019 • Bath, Royaume-Uni
Résumé:
The UK's biggest biennial conference for MS professionals brings together scientists, clinicians, academics and health care professionals to share the latest breakthroughs in multiple sclerosis research.
Contact:
Email.: MSFrontiers@mssociety.org.uk
Sujets:
MS, multiple sclerosis, progressive MS, relapsing MS, CIS, autoimmune, neurological, physiotherapy, Disease Modifying Therapies, Symptom management, health economics, PPI, patient involvement, neuroprotection, myelin regeneration, immunomodulation.
Identifiant de l'évènement:
1236490
Sujets apparentés:
3
ECC-2019 — 3rd Annual European Clinical Conference
13 sep 2019 - 15 sep 2019 • Vienne, Autriche
Organisateur:
The European Society for Translational Medicine (EUSTM) and European Journal of Molecular & Clinical Medicine (EJMCM)
Contact:
Tél.: [+4318923562];     Email.: ecc-2019@eutranslationalmedicine.org
Sujets:
Medicine Specialties: Internal Medicine, all sub specialties including Cardiovascular diseases, Gastrointestinal and Hepatic diseases, Respiratory disorders, Infectious diseases, Endocrine and metabolic disorders, Hematology, Musculoskeletal disorders, Allergy-Immunology, Oncology, Rare/Orphan diseases, Renal diseases, Rheumatology, Genetic disorders, Geriatrics, General Practice and Other. General Surgery Accidents/Trauma, Peri & Post Operative Care, Trauma & Burn Surgery, Gynecological Surgery, Cardiothoracic Surgery, Gastrointestinal Surgery, Hepatobiliary Surgery, Respiratory Surgery, Endocrine Surgery, Orthopedic Surgery, Transplant Surgery, Endoscopic Surgery, Oncological Surgery, Robotic Surgery, Neuro Surgery and others. Cardiovascular Radiology, Emergency Radiology, Gastrointestinal Radiology, Genitourinary Radiology, Musculoskeletal Radiology, Pediatric Radiolog, y Neuroradiology Radiotherapy, Interventional Radiology, Ultrasound, CT, Magnetic resonance imaging (MRI), Positron emission tomography (PET), Molecular imaging, Imaging Technology, Radioimmunoassay, Biomedical Radiology, Imaging Radiophysics, Radiobiology and Radiopharmacology, Radioisotope therapy, Image Guided Radiation Therapy, in vitro Radionuclide procedure, Oncology and hematologic diseases & Others.
Identifiant de l'évènement:
1202868
Sujets apparentés:
4
SCOE — SCOE Summit for Clinical Trials Operations Executives Europe 2019
17 sep 2019 - 18 sep 2019 • Barcelona, Espagne
Résumé:
Building on the success of its long-running US-based counterpart, Summit for Clinical Trials Operations Executives Europe (SCOPE Europe) is a two-day event serving clin ops execs, functional heads, category managers, and those responsible for the planning and management of clinical trials in Europe and the Rest of the World. The event will feature opening and closing plenary keynote sessions, five conference tracks, interactive breakout discussion groups, and networking. It is an opportunity for leaders from large, mid-sized, and small pharma, specialty pharma, biotech, vendor companies, and academic research centers to come together to share best practices and discuss the new era of analytics-driven and patient-centric trials. Topics to be discussed include protocol development, global site selection, feasibility, site management, patient engagement, enrollment planning, patient recruitment, patient retention, improving site-study activation and performance, functional/full-service outsourcing and partnerships, new regulations and guidelines, Risk-Based Monitoring (RBM), clinical technology, big data and analytics, Real-World Data (RWD), Artificial Intelligence (AI), resource management, trial forecasting, and improving overall quality and speed of clinical trials.
Contact:
Cambridge Healthtech Institute;     Tél.: [7819725400];     Email.: chi@healthtech.com
Sujets:
Protocol Development, global site selection, feasibility, site management, patient engagement, enrollment planning, patient recruitment, patient retention, improving site-study activation and performance, functional/full-service outsourcing and partnerships, new regulations and guidelines, Risk-Based Monitoring (RBM), clinical technology, big data and analytics, Real-World Data (RWD), Artificial Intelligence (AI), resource management, trial forecasting
Identifiant de l'évènement:
1236739
5
Biosimilars — SMi's 10th Annual Biosimilars Conference
25 sep 2019 - 26 sep 2019 • Londres, Royaume-Uni
Contact:
Tél.: [02078276000];     Email.: ssapal@smi-online.co.uk
Sujets:
Biosimilar, Biobetters, biologic, generic drug, immunogenicity, innovator, interchangeability, pharmacist, doctors, dosage, legislation, commercialising biosimilars, patent protection
Identifiant de l'évènement:
1219407
6
SAS19 — Seed and Soil: Mechanisms of Metastasis
07 oct 2019 - 09 oct 2019 • Berlin, Allemagne
Résumé:
We invite you to join us at the 2nd joint EACR-MRS Conference on Seed and Soil: Mechanisms of Metastasis. This is a joint conference organised by the European Association for Cancer Research (EACR) and Metastasis Research Society (MRS).

Metastasis formation is responsible for over 90% of cancer patient deaths, largely due to the fact that therapies are generally ineffective against detectable metastatic tumors. There is thus a crucial need to mechanistically understand the cellular, tissue and whole-body processes driving metastasis formation in order to identify effective therapeutic strategies. This conference will give an in-depth overview of our current knowledge on cancer, stromal and immune cell centred mechanisms promoting metastasis formation presented by world-leading researchers in the field.

Contact:
Tél.: [0115 951 5065];     Email.: l.strachan@nottingham.ac.uk
Sujets:
cancer, tumor, tumour, metastasis, therapeutic, stromal, immune, cell, research, therapy, treatment, oncology
Identifiant de l'évènement:
1201597
Sujets apparentés:
7
Orphan Drugs 2019 — Rare Diseases & Orphan Drugs 2019
24 oct 2019 - 25 oct 2019 • Rome, Italie
Résumé:
Hi, I'm Spandana M Program Manager of Orphan Drugs 2019. I would like to welcome you, to participate as a speaker/exhibitor to our upcoming World congress on “RARE DISEASES & ORPHAN DRUGS 2019 “which is to be held on October 24-25,2019 Rome, Italy. The Theme falls on “Redefining the possibilities with research in Rare Diseases & Orphan Drugs”.
Contact:
Tél.: [359-825-18874];     Email.: euroorphandrugs@gmail.com
Identifiant de l'évènement:
1233136
8
MAP 2019 — Molecular Analysis for Personalised Therapy
07 nov 2019 - 09 nov 2019 • Londres, Royaume-Uni
Organisateur:
Cancer Research UK (CRUK), the European Society for Medical Oncology (ESMO) and Unicancer
Résumé:
MAP 2019 - Molecular Analysis for Personalised Therapy is a unique meeting established by global opinion leaders. The congress aims to integrate insights from tumour sample analysis into daily practice. The MAP Congress has grown into an influential, highly interactive forum which is a natural choice for specialists working in precision medicine in oncology. The Congress programme is based on the genomic information obtained through the sequencing of all tumours and the tumour environment.
Contact:
Tél.: [+41 91 97 31 947];     Email.: meetings@esmo.org
Sujets:
oncology, personalised medicine, precision medicine, genome alterations, genome sequencing, molecular analysis
Identifiant de l'évènement:
1198571
9
ECRMC — The 7th Edinburgh Clinical Research Methodology Course
11 nov 2019 - 12 nov 2019 • Edinburgh, Royaume-Uni
Résumé:
A two-day course providing a comprehensive overview of the methods and frameworks currently required to perform cutting-edge clinical research. The course will consist of interactive lectures and opportunities for delegates to network with distinguished researchers, all of whom are recognised experts in their field. Aimed at practitioners at all levels from all disciplines (medical, allied health professionals, nursing and midwifery staff and scientists) who have an interest in or are actively engaged in clinical research.
Contact:
Tél.: [0131 537 3355];     Email.: Education@edinburghcrf.ed.ac.uk
Identifiant de l'évènement:
1222843
10
ECTMC — Edinburgh Clinical Trials Management Course
14 nov 2019 - 15 nov 2019 • Edinburgh, Royaume-Uni
Résumé:
This 2 day course provides an introduction to the management of randomised control trials (RCTS), by giving an overview of the standard processes and legal requirements necessary to undertake clinical research.
Contact:
Education, Edinburgh Clinical Research Facility;     Tél.: [0131 537 3355];     Email.: education@edinburghcrf.ed.ac.uk
Identifiant de l'évènement:
1233138
11
ESMO Sarcoma and GIST 2020 — ESMO Sarcoma and GIST Symposium 2020
03 fév 2020 - 05 fév 2020 • Milan, Italie
Résumé:
ESMO’s Sarcoma & GIST Symposium is a highly specialised meeting bringing together the most brilliant medical minds working on these tumour types. The Symposium is known as the place of choice for international networking and collaboration, featuring discussions with the key opinion leaders in these rare sub-entities.The Symposium brings translational researchers and clinicians together and builds on an integrated approach for improved patient outcomes.
Contact:
Tél.: [+41 91 97 31 939];     Email.: registration@esmo.org
Sujets:
sarcoma, gist, gastrointestinal stromal tumours, rare cancers, translational research, oncology, cancer, soft tissue sarcomas, medical oncology, surgical oncology, radiotherapy, pathology
Identifiant de l'évènement:
1229984
Sujets apparentés:


Conference-Service.com met à la disposition de ses visiteurs des listes de conférences et réunions dans le domaine scientifique. Ces listes sont publiées pour le bénéfice des personnes qui cherchent une conférence, mais aussi, bien sûr, pour celui des organisateurs. Noter que, malgré tout le soin que nous apportons à la vérification des données entrées dans nos listes, nous ne pouvons accepter de responsabilité en ce qui concerne leur exactitude ou étendue. Pensez donc à vérifier les informations présentées avec les organisateurs de la conférence ou de la réunion avant de vous engager à y participer!

Les organisateurs peuvent soumettre une réunion ou une conférence pour inclusion dans nos listes, et ceci gratuitement.

Dernière mise à jour: 05 Juin 2019